↓ Skip to main content
Altmetric
What is this page?
Embed badge
Share
Share on Twitter
Share on Facebook
Share by email
Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab
Overview of attention for article published in Pharmaceutical Medicine, September 2018
Altmetric Badge
About this Attention Score
Among the highest-scoring outputs from this source (#44 of 151)
Above-average Attention Score compared to outputs of the same age (64th percentile)
Mentioned by
twitter
1
X user
patent
2
patents
Citations
dimensions_citation
12
Dimensions
Readers on
mendeley
55
Mendeley
Summary
X
Patents
Dimensions citations
So far, Altmetric has seen
2
patents that reference this research output.
Subcutaneous HER2 antibody formulations
Grant US-11654105-B2
United States of America
23 May 2023
Subcutaneous HER2 antibody formulations
Grant US-10849849-B2
United States of America
01 Dec 2020